SEARCH

SEARCH BY CITATION

References

  • 1
    International Agency for Research on Cancer. Screening for cancer of the uterine cervix. From the IARC working group on cervical cancer screening and the UICC project group on the evaluation of screening programmes for cancer. IARC Sci Publ 1986; 76: 1315.
  • 2
    International Agency for Research on Cancer. IARC/WHO Handbooks of cancer prevention, Vol 10: Cervix cancer screening. IARC Press, Lyon, 2005. 302 p.
  • 3
    Arbyn M, Dillner J, Schenck U, Nieminen P, Weidepass E, Da Silva JD, Jordan J, Ronco G, McCoogan E, Patnick J, Sparen B, Herbert A, et al. Chapter 3. Methods for screening and diagnosis. In: Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, Wiener HG, Herbert A, Daniel J, von Karsa L, eds. European guidelines of quality assurance in cervical cancer screening, 2nd edn. Office for Official Publications of the European Communities, Brussels, 2008. 69152.
  • 4
    Bulkmans NWJ, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJP, Bulk S, Voorhorst FJ, Verheijen RHM, van Groningen K, Boon ME, Ruitinge W, can Ballegooijen M, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007; 370: 17641772.
  • 5
    Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Forslund O, Hansson B-G, Rylander E, Dillner J. Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer. NEJM 2007; 357: 15891597.
  • 6
    Dillner J, Rebolj M, Birembaut P, Petry K-U, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 2008; 337: a1754.
  • 7
    Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, Hingmire S, Malvi SG, Thorat R, Kothari A, Chinoy R, Kelkar R, et al. HPV screening for cervical cancer in rural India. NEJM 2009; 360: 138594.
  • 8
    Kitchener HC, Almonte M, Thomson C, Wheeler P, Sargent A, Stoykova B, Gilham C, Baysson H, Roberts C, Dowie R, Desai M, Mather J, et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol 2009; 10: 67282.
  • 9
    Nieminen P, Kotaniemi L, Hakama M, Tarkkanen J, Martikainen J, Toivonen T, Ikkala J, Luostarinen T, Anttila A. A randomised public-health trial on automation-assisted sceening for cervical cancer in Finland: performance with 470,000 invitations. Int J Cancer 2005; 115: 30711.
  • 10
    Anttila A, Hakama M, Kotaniemi-Talonen L, Nieminen P. Alternative technologies in cervical cancer screening: a randomised evaluation trial. BMC Publ Health 2006; 6: 252.
  • 11
    Nieminen P, Viikki M, Hakama M, Anttila A. A prospective and randomised public-health trial on neural network assisted screening for cervical cancer in Finland. The results of the first year. Int J Cancer 2003; 103: 4226.
  • 12
    Nieminen P, Kotaniemi L, Hakama M, Tarkkanen J, Martikainen J, Toivonen T, Ikkala J, Anttila A. Randomised evaluation trial for cervical cancer screening: results after 777 000 invitations. J Med Screening 2007; 14: 2328.
  • 13
    Anttila A, Nieminen P. Cervical cancer screening programme in Finland. Eur J Cancer 2000; 36: 220914.
  • 14
    Monto K, Nieminen P. Gynekologisten irtosolunäytteiden vuosittainen kokonaismäärä ja raportointitavat Suomessa. Suom Laakaril 2005; 18–19: 209397. [Annual number and reporting of gynaecological smear samples in Finland. Finnish Medical Journal 2005;18–19:2093-2097, in Finnish.]
  • 15
    Ronco G, Cuzick J, Pierotti P, Cariaggi MP, Dalla Palma P, Naldoni C, Ghiringhello B, Giorgi-Rossi P, Minucci D, Parisio F, Pojer A, Schiboni ML, et al. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. BMJ 2007; 335: 28.
  • 16
    Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol 2008; 111: 16777.
  • 17
    Anttila A, Kotaniemi-Talonen L, Leinonen M, Hakama M, Laurila P, Tarkkanen J, Malila N, Nieminen P. Cervical cancer and severe intraepithelial neoplasia rate in primary HPV-DNA screening with cytology triage: a randomised study within an organised programme. Br Med J 2010; 340: c1804.
  • 18
    Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010; 11: 24957.
  • 19
    Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. JNCI 2009; 101: 112.
  • 20
    Doornewaard H, van der Schouw YT, van der Graaf Y, Bos AB, Habbema JD, van den Tweel JG. The diagnostic value of computer-assisted primary cervical smear screening: a longitudinal cohort study. Mod Pathol 1999; 12: 9951000.
  • 21
    Kok MR, Boon ME. Consequences of neural network technology for cervical screening: increase of diagnostic consistency and increase of positive scores. Cancer 1996; 78: 112117.
  • 22
    Kok MR, Boon ME, Schreiner–Kokn PG, Koss LG. Cytological recognition of invasive squamous cancer of the uterine cervix: comparison of conventional light-microscopical screening and netural network-based screening. Hum Pathol 2000; 31: 2338.
  • 23
    Hristova L, Hakama M. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017. Acta Oncol 36 Suppl 9: 160.
  • 24
    Anttila A, Pukkala E, Söderman B, Kallio M, Nieminen P, Hakama M. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: a recent increase in cervical cancer incidence. Int J Cancer 1999; 83: 5965.
  • 25
    Nieminen P, Kallio M, Anttila A, Hakama M. Organised versus spontaneous pap-smear screening for cervical cancer, a case-control study. Int J Cancer 1999; 83: 558.
  • 26
    van den Akker-van Marle ME, van Ballegooijen M, Habbema JD. Low risk of cervical cancer during a long period after negative screening in the Netherlands. Br J Cancer 2003; 88: 10541057.
  • 27
    Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003; 89: 8893.
  • 28
    Sasieni P, Castanon A, Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. Br Med J 2009; 339: b2968.